US Patent 9211263 Compositions and methods of treating metabolic disorders
Patent 9211263 was granted and assigned to Elcelyx Therapeutics Inc. on December, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9211263 Compositions and methods of treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
